Page 15 - Drug Controller News Today

Indias first general robotic surgery system to hit markets in 4-6 months SS Innovations is planning to make 100 units this year of the multi arm novel Mantra Surgical Robotic System indigenously developed over the last three years. Plans are to make and sell over 1,000 units within the next five years PB Jayakumar | February 26, 2021 | Updated 22:52 IST Plans are to make and sell over 1,000 units within the next five years New Delhi-based SS Innovations, promoted by renowned robotic cardiothor...

The city-based PNB Vesper Life Sciences has successfully completed phase 2 clinical trials of PNB-001 (GPP-Baladol), its proprietary drug to treat the coronavirus infection and said it will soon move the government for deploying the drug for emergency use. The company, which has its labs in England, had in early September 2020 received the approval from the Drug Controller General (DCGI) to conduct the phase 2 clinical trial of GPP-Baladol in patients with moderate infection of the pandemic w...

Notices issued on plea saying Covishield unsafe According to the petitioner, Asif Riaz, of Anna Nagar, there was no adverse reaction in the first 10 days, but he woke up on October 11 with a severe headache. Share Via Email   |  A+A A- By Express News Service CHENNAI: The Madras High Court on Friday issued notices to the Central government and Serum Institute of India on a plea to declare the Covishield vaccine unsafe. The petitioner said he volunteered for the vaccine trial and had sid...

Last Updated: Covid-19: Two New Vaccines Show Less Efficacy Against South African Strain Data from two new coronavirus vaccine trials have revealed that they have less efficacy in protecting the people from the new South African variant. Data from two new coronavirus vaccine trials have revealed that they have less efficacy in protecting the people from the new South African variant. The trials from Novavax and Johnson & Johnson vaccine indicated that their vaccines have less efficacy. Nov...

India’s Covid-19 vaccine drive has been hampered by turnout as low as 22% in some states, as fears over the safety of the vaccine and the spread of misinformation has fuelled widespread hesitancy. On Saturday, India launched the world’s largest vaccination programme as it began the massive task of vaccinating its 1.3 billion citizens against coronavirus. On the first day of India’s vaccine drive on Saturday, more than 200,000 vaccinations were...

India on Saturday started inoculating health workers in what is expected to be the world 39;s biggest coronavirus vaccination programme.

Covid Vaccine: The Hyderabad-based vaccinemaker will roll out 14 consignments from its factory today. Hyderabad: The first batches of Covaxin, the Bharat Biotechs coronavirus vaccine, left Hyderabad early this morning for Delhi and 10 other cities, a day after Serum Institute of India rolled out its vaccine against COVID-19 ahead of the nationwide inoculation drive on Saturday which officials say will be the worlds biggest. The Hyderabad-based vaccinemaker will roll out 14 consignments from i...

Serum Institute of India’s COVID-19 vaccine to reach Odisha Tuesday afternoon Post News Network Bhubaneswar: The first consignment containing vials of Covishield vaccine, Serum Institute of India’s COVID-19 vaccine, will reach Odisha Tuesday as the first consignment for the same has already been dispatched from Pune. While the consignment of the vaccine was dispatched from Pune to several places across the country early Tuesday morning, SpiceJet airline’s Pune-Bhubaneswar ca...

"Stand By, India": Serum Institute Sends Out Vaccines, 1st Batch In Delhi Covishield Vaccine: Thirty crore people will be administered the vaccine in the first phase of the nationwide inoculation drive which will begin on January 16. Updated: January 12, 2021 1:26 pm IST New Delhi: The first batches of Covishield, the Serum Institute of Indias coronavirus vaccine, left Pune early this morning for Delhi and 12 other cities, four days ahead of the nationwide inoculation drive against COVID-1...

Adar Poonawalla called the roll out of the Covishield vaccine an "emotional moment" New Delhi: Serum Institute of India CEO Adar Poonawalla tweeted that it was an "emotional moment" for his team at the Pune facility as the first shipments of the Covishield vaccine rolled out today. 56.5 lakh doses of Covishield, Indias first coronavirus vaccine, left the SII this morning for various cities including Delhi, Chennai, Bengaluru, Lucknow, Kolkata, Guwahati and Patna. Mr Poonawalla shared two photo...